Skip to main content

Day: December 19, 2025

QGold Resources Delivers Transformational Year With Quartz Mountain Gold Project Acquisition, $11.5m Financing, and Updated Mineral Resource Estimate; Advances 2026 Development Strategy

COMPLETED $11,500,000 FULLY ALLOCATED PRIVATE PLACEMENT FINANCING WITH BMOCOMPLETED ACQUISITION OF QUARTZ MOUNTAIN ADVANCED GOLD PROJECT IN OREGON, UNITED STATES FROM ALAMOS GOLDFILED NEW NI 43-101 TECHNICAL REPORT ON MINERAL RESOURCE ESTIMATE FOR QUARTZ MOUNTAIN GOLD PROJECTCOMMENCED TRADING ON OTCQB® VENTURE MARKET UNDER “QGLDF”PRELIMINARY ECONOMIC ASSESSMENT (“PEA”) OF QUARTZ MOUNTAIN GOLD PROJECT STARTED WITH KAPPES CASSIDAYINITIATED TWO DRILL CAMPAIGNS AT MINE CENTRE GOLD PROJECT IN CANADAADVANCED PERMITTING AT QUARTZ MOUNTAIN GOLD PROJECT WITH ENGAGEMENT OF SLR INTERNATIONALBOARD OF DIRECTORS STRENGTHENED WITH INDUSTRY LEADERS: SCOTT PARSONS, VP EXPLORATION OF ALAMOS GOLD, AND JAMSHEED MEHTA, FORMER VICE CHAIR AT BMO CAPITAL MARKETSTORONTO, Dec. 19, 2025 (GLOBE NEWSWIRE) — Q-Gold Resources Ltd. (TSXV: QGR;...

Continue reading

AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711

IRVINE, Calif., Dec. 19, 2025 (GLOBE NEWSWIRE) — AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE American: AEON), a biopharmaceutical company seeking accelerated and full-label U.S. market entry by developing ABP-450 (prabotulinumtoxinA) as a BOTOX (onabotulinumtoxinA) biosimilar, today reported the grants in December totaling 392,158 restricted stock units (RSUs) of the Company’s common stock to newly hired non-executive employees of the Company. The awards were approved by the Company’s Board of Directors under the Company’s 2025 Inducement Incentive Plan, with a grant date of December 11, 2025 and vesting commencement dates in December 2025. The RSUs vest over four years, 25% on each annual anniversary of the vesting commencement date. The awards are subject to the terms and conditions of the Inducement Plan and the terms...

Continue reading

Vireo Growth Inc. to Acquire Additional Outstanding Senior Secured Convertible Notes of Schwazze

MINNEAPOLIS, Dec. 19, 2025 (GLOBE NEWSWIRE) — Vireo Growth Inc. (“Vireo”) (CSE: VREO; OTCQX: VREOF) (“Vireo” or the “Company”) today announced that it plans to acquire additional outstanding senior secured convertible notes (the “Notes”) of Medicine Man Technologies Inc. (dba “Schwazze”) from third-party noteholders. Total outstanding principal plus accrued interest of the acquired Notes is approximately $2.6 million, but the Notes will be acquired at a substantial discount to par value for total consideration of approximately $1.6 million payable in subordinate voting shares of the Company at closing at a price per share of $0.54. Upon closing of the transaction, which is expected to occur later this month, Vireo will have acquired approximately 89% of the outstanding senior secured convertible notes of Schwazze. Completion of...

Continue reading

Hypercharge Announces Appointment of Chief Operating Officer and Peterson Capital Engagement

VANCOUVER, British Columbia, Dec. 19, 2025 (GLOBE NEWSWIRE) — Hypercharge Networks Corp. (TSXV: HC; OTC: HCNWF; FSE: PB7) (the “Company” or “Hypercharge”), a leading, smart electric vehicle (EV) charging solutions provider and network operator, is pleased to announce the appointment of Chris Koch as Chief Operating Officer. As Head of Growth & Partnerships, Mr. Koch has played a foundational role in building Hypercharge’s sales engine, customer onboarding, and fulfillment capabilities. In his new role as Chief Operating Officer, Mr. Koch will oversee sales, fulfillment, and professional services, while expanding his focus on growth across Eastern Canada and the United States, advancing large strategic partnerships, and strengthening delivery at scale as the company continues to grow. Mr. Koch brings more than 20 years of senior...

Continue reading

ExGen Resources Completes Acquisition of MTB Metals

VANCOUVER, British Columbia, Dec. 19, 2025 (GLOBE NEWSWIRE) — ExGen Resources Inc. (TSXV: EXG; OTC: BXXRF) (“ExGen”) and MTB Metals Corp. (TSXV: MTB, OTCQB: MBYMF, Frankfurt: E8H) (“MTB”) are pleased to announce completion of the previously disclosed plan of arrangement (the “Arrangement”), pursuant to which ExGen acquired all of the issued and outstanding securities of MTB by way of a court-approved plan of arrangement under the Business Corporations Act (British Columbia). Commenting on the acquisition, ExGen CEO Jason Riley said: “ExGen is pleased to welcome the MTB team and shareholders to our company. The integration of MTB marks a pivotal milestone for ExGen. This partnership isn’t just about scale; it’s about combining our shared vision to capture an incredible time in the market that we believe has only just begun....

Continue reading

CN Statement on UP-NS STB Filing

MONTREAL, Dec. 19, 2025 (GLOBE NEWSWIRE) — The application filed this morning by Union Pacific and Norfolk Southern fails to demonstrate that the merger would enhance competition or generate significant public benefits that would require a merger. It falls well below both the 2001 and old merger rules set out by the Surface Transportation Board (STB). Protecting competition is not optional, it is essential to keep costs down and the economy sound. The fact is that this merger would reduce rail transportation options for customers while creating a single entity that controls more than 40% of the US freight rail market. Without real railroad competition, prices go up and consumers lose. CN will be actively participating in the STB process and encourages all stakeholders to participate to ensure all voices are heard and that competition...

Continue reading

ValOre Metals Corp. Announces Voting Results of Annual General Meeting

VANCOUVER, British Columbia, Dec. 19, 2025 (GLOBE NEWSWIRE) — ValOre Metals Corp. (“ValOre” or the “Company”); (TSX‐V: VO; OTCQB: KVLQF; Frankfurt: KEQ0) today announced the voting results of its recent annual general meeting of shareholders (“AGM”), which was held on December 18, 2025. Shareholders approved setting the size of the Board at five, including the election of each director nominee. Detailed results of the vote for the election of directors are as follows:Nominee # Voted For %Voted For # Votes Withheld % Votes WithheldNicholas Smart 81,395,712 99.32% 560,345 0.68%James Paterson 81,345,656 99.26% 610,401 0.74%Dale Wallster 80,591,757 98.34% 1,364,300 1.66%Garth Kirkham 81,395,712 99.32% 560,345 0.68%Darren Klinck 81,395,712 99.32% 560,345 0.68%         Shareholders also approved the...

Continue reading

Nexus Industrial REIT Announces the Acquisition of Two Montreal Industrial Buildings

OAKVILLE, Ontario, Dec. 19, 2025 (GLOBE NEWSWIRE) — Nexus Industrial REIT (“Nexus” or the “REIT”) (TSX: NXR.UN) is pleased to announce the acquisition of two industrial buildings located in Montreal, Quebec for $40.1 million. The buildings have a combined gross leasable area (“GLA”) of 277 thousand square feet and are under long-term leases expiring in November 2032. The going in cap rate on the leases is 6.6%, which resets to an estimated stabilized market rate of 10.4% in 2028. The acquisition was funded by drawing on the REIT’s credit facility. “The opportunity was too good for us to pass up,” said Kelly Hanczyk, CEO of Nexus Industrial REIT. “These two well-located, high-quality buildings will be immediately accretive to AFFO and NAV per unit. They are under long-term leases with significant mark-to-market potential...

Continue reading

World Renowned Law Firm Grant & Eisenhofer Files Class Action Lawsuit Against Canadian Banks CIBC and RBC Alleging Illegal Stock Market Manipulation of Quantum BioPharma Shares

TORONTO, Dec. 19, 2025 (GLOBE NEWSWIRE) — Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma”), understands that Quantum BioPharma shareholder Paul Durkacz has filed a class action lawsuit alleging that investors in Quantum BioPharma were the victims of stock manipulation. The suit alleges that between January 6, 2021, and October 15, 2025, shareholders who sold securities of Quantum Biopharma Ltd., formerly known as FSD Pharma Inc., were significantly and materially harmed. A link to this complaint can be found here. Quantum Biopharma intends to seek appointment as a lead plaintiff in this class action in order to assist in protecting its shareholders. For more information visit: www.quantumbiopharma.com and https://www.quantumbiopharma.com/quantum-biopharma-vs-banks Quantum Biopharma Ltd. has renewed...

Continue reading

Capstone Asset Management Inc. announces estimated fourth quarter 2025 cash distributions for ETF Series of Capstone Funds

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES LANGLEY, British Columbia, Dec. 19, 2025 (GLOBE NEWSWIRE) — Capstone Asset Management Inc. (“Capstone”) today announced the estimated fourth quarter 2025 cash distributions for the ETF Series units of the Capstone Funds. The record date for the distributions is December 30, 2025. All distributions are payable on January 7, 2026. No annual notional capital gains distributions are expected to be made for 2025 in respect of the ETF Series units of the Capstone Funds. The actual taxable amounts of distributions for 2025, including the tax characteristics of the distributions, will be reported to CDS Clearing and Depository Services Inc. in early 2026. Unitholders can contact their brokerage firm for this information. The per-unit fourth...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.